Curt D Sigmund Selected Research

Angiotensins

1/2021	β-Arrestin-Biased Agonist Targeting the Brain AT1R (Angiotensin II Type 1 Receptor) Increases Aversion to Saline and Lowers Blood Pressure in Deoxycorticosterone Acetate-Salt Hypertension.
1/2020	Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice.
2/2015	Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ.
3/2013	Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension.
6/2003	Minireview: overview of the renin-angiotensin system--an endocrine and paracrine system.
2/2002	Lower blood pressure in floxed angiotensinogen mice after adenoviral delivery of Cre-recombinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Curt D Sigmund Research Topics

Disease

60	Hypertension (High Blood Pressure) 01/2022 - 01/2002
7	Pre-Eclampsia (Preeclampsia) 01/2021 - 03/2007
6	Obesity 01/2021 - 06/2004
6	Atherosclerosis 01/2017 - 05/2004
5	Weight Gain 01/2022 - 03/2011
5	Polydipsia 01/2021 - 03/2011
5	Inflammation (Inflammations) 01/2016 - 05/2004
3	Essential Hypertension 01/2022 - 03/2007
3	Dehydration (Water Stress) 01/2018 - 02/2015
3	Insulin Resistance 11/2017 - 03/2010
3	Body Weight (Weight, Body) 01/2016 - 03/2009
2	Heart Diseases (Heart Disease) 01/2021 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2005
2	Neoplasms (Cancer) 11/2019 - 05/2004
2	Heart Failure 11/2018 - 05/2004
2	Vascular Diseases (Vascular Disease) 01/2018 - 01/2017
2	AIDS-Related Complex (ARC) 12/2017 - 04/2011
2	Vascular Remodeling 12/2016 - 01/2016
2	Pathologic Constriction (Stenosis) 03/2016 - 03/2013
2	Fibrosis (Cirrhosis) 01/2016 - 03/2010
2	Polyuria 03/2013 - 03/2011
2	Hypertrophy 04/2008 - 03/2008
2	Ganglion Cysts (Ganglion) 09/2002 - 01/2002
1	Albuminuria 01/2021
1	Stroke (Strokes) 01/2021
1	Cardiovascular Abnormalities 11/2018
1	Diabetes Mellitus 11/2018
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2018
1	Hypoxia (Hypoxemia) 10/2018
1	Renal Hypertension 10/2018
1	Glucose Intolerance 11/2016

Drug/Important Bio-Agent (IBA)

21	SaltsIBA 01/2022 - 09/2002
17	ReninIBA 01/2022 - 01/2002
17	Angiotensin IIIBA 01/2022 - 02/2002
15	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 03/2010
14	AngiotensinogenIBA 12/2017 - 02/2002
8	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2022 - 03/2011
7	Acetates (Acetic Acid Esters)FDA Link 01/2022 - 03/2013
7	Vasopressins (Vasopressin)IBA 01/2022 - 01/2002
7	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2022 - 03/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
6	LeptinIBA 01/2021 - 03/2009
6	AngiotensinsIBA 01/2021 - 02/2002
6	PPAR gammaIBA 03/2010 - 06/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 10/2002
4	SodiumIBA 01/2021 - 03/2011
4	Arginine Vasopressin (Argipressin)IBA 10/2018 - 09/2002
4	Superoxides (Superoxide)IBA 01/2017 - 10/2002
3	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 09/2002
3	Peptides (Polypeptides)IBA 01/2021 - 05/2004
3	Messenger RNA (mRNA)IBA 01/2020 - 02/2005
3	Cullin Proteins (Cullins)IBA 10/2018 - 07/2015
3	CytokinesIBA 01/2018 - 05/2004
3	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 03/2010
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2016 - 11/2011
3	ThiazolidinedionesIBA 12/2015 - 01/2005
3	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2015 - 06/2008
3	LigandsIBA 05/2013 - 01/2005
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2008 - 06/2005
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2022 - 09/2002
2	Type 1 Angiotensin ReceptorIBA 01/2021 - 02/2015
2	Hormones (Hormone)IBA 01/2020 - 11/2015
2	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2016
2	Phosphotransferases (Kinase)IBA 10/2018 - 06/2015
2	Ligases (Synthetase)IBA 12/2017 - 08/2008
2	UbiquitinIBA 12/2017 - 08/2008
2	Insulin (Novolin)FDA Link 11/2016 - 05/2013
2	ApolipoproteinsIBA 01/2016 - 05/2013
2	Pioglitazone (Actos)FDA Link 07/2015 - 03/2013
2	EnzymesIBA 01/2015 - 11/2011
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2013 - 10/2012
2	Cre recombinaseIBA 04/2011 - 02/2002
1	Aquaporin 2IBA 01/2022
1	ElectrolytesIBA 01/2022
1	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 01/2021
1	MelanocortinsIBA 01/2021
1	ArrestinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2020
1	Endothelins (Endothelin)IBA 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 01/2020
1	Cyclin EIBA 11/2019
1	CyclinsIBA 11/2019
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	Prostaglandins FIBA 10/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2018
1	Tyrosine (L-Tyrosine)FDA Link 10/2018
1	Lysine (L-Lysine)FDA Link 10/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 12/2016
1	CollagenIBA 11/2016
1	Insulin ReceptorIBA 11/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2016
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016

Therapy/Procedure

5	Therapeutics 03/2020 - 01/2007
2	Intravenous Injections 09/2002 - 01/2002
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 11/2018